Patents by Inventor Dale R. Cameron

Dale R. Cameron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AZAINDOLINE COMPOUNDS AS GRANZYME B INHIBITORS
    Publication number: 20200062803
    Abstract: Azaindoline compounds as granzyme B inhibitors, compositions that include the compounds, and methods for using the compounds. Methods for treating cutaneous scleroderma, epidermolysis bullosa, radiation dermatitis, alopecia areata, and discoid lupus erythematosus are provided.
    Type: Application
    Filed: April 1, 2019
    Publication date: February 27, 2020
    Applicant: viDA Therapeutics Inc.
    Inventor: Dale R. Cameron
  • Cyclic urea compounds as granzyme B inhibitors
    Patent number: 10537652
    Abstract: Cyclic urea compounds as Granzyme B inhibitors, compositions that include the compounds, and methods for using the compounds. Methods for treating cutaneous scleroderma, epidermolysis bullosa, radiation dermatitis, alopecia areata, and discoid lupus erythematosus are provided.
    Type: Grant
    Filed: July 31, 2015
    Date of Patent: January 21, 2020
    Assignee: viDA Therapeutics Inc.
    Inventor: Dale R. Cameron
  • Indoline compounds as granzyme B inhibitors
    Patent number: 10329324
    Abstract: Granzyme B inhibitor compounds, compositions that include the compounds, and methods for using the compounds. The compounds of the invention have advantageous water solubility and effectively inhibit Granzyme B.
    Type: Grant
    Filed: March 27, 2017
    Date of Patent: June 25, 2019
    Assignee: viDA Therapeutics
    Inventor: Dale R. Cameron
  • CYCLIC UREA COMPOUNDS AS GRANZYME B INHIBITORS
    Publication number: 20190151484
    Abstract: Cyclic urea compounds as Granzyme B inhibitors, compositions that include the compounds, and methods for using the compounds. Methods for treating cutaneous scleroderma, epidermolysis bullosa, radiation dermatitis, alopecia areata, and discoid lupus erythematosus are provided.
    Type: Application
    Filed: July 31, 2015
    Publication date: May 23, 2019
    Applicant: viDA Therapeutics Inc.
    Inventor: Dale R. Cameron
  • Azaindoline compounds as granzyme B inhibitors
    Patent number: 10246487
    Abstract: Azaindoline compounds as granzyme B inhibitors, compositions that include the compounds, and methods for using the compounds. Methods for treating cutaneous scleroderma, epidermolysis bullosa, radiation dermatitis, alopecia areata, and discoid lupus erythematosus are provided.
    Type: Grant
    Filed: July 31, 2015
    Date of Patent: April 2, 2019
    Assignee: viDA Therapeutics Inc.
    Inventor: Dale R. Cameron
  • GRANZYME B INHIBITOR FORMULATIONS AND METHODS FOR THE TREATMENT OF BURNS
    Publication number: 20190038602
    Abstract: Formulations for treating burns and burn wound healing comprising a Granzyme B inhibitor and a pharmaceutically acceptable carrier, and methods for treating burns and for burn wound healing using the formulations.
    Type: Application
    Filed: February 3, 2017
    Publication date: February 7, 2019
    Applicants: viDA Therapeutics, Inc., The University of British Columbia
    Inventors: David Granville, Yue Shen, Maria Fernanda Zuluaga Estrada, Dale R. Cameron, Anthony S.K. Boey
  • Covalent granzyme B inhibitors
    Patent number: 9969772
    Abstract: Covalent Granzyme B inhibitors, compositions that include the compounds, and methods for using the compounds. A method for treating cutaneous scleroderma, epidermolysis bullosa, radiation dermatitis, alopecia areata, and discoid lupus erythematosus are provided.
    Type: Grant
    Filed: September 29, 2016
    Date of Patent: May 15, 2018
    Assignee: viDA Therapeutics Inc.
    Inventor: Dale R. Cameron
  • Proline compounds as Granzyme B inhibitors
    Patent number: 9969770
    Abstract: Proline compounds as Granzyme B inhibitors, compositions that include the compounds, and methods for using the compounds. Methods for treating cutaneous scleroderma, epidermolysis bullosa, radiation dermatitis, alopecia areata, and discoid lupus erythematosus are provided.
    Type: Grant
    Filed: September 29, 2016
    Date of Patent: May 15, 2018
    Assignee: viDA Therapeutics Inc.
    Inventor: Dale R. Cameron
  • INDOLINE COMPOUNDS AS GRANZYME B INHIBITORS
    Publication number: 20180057528
    Abstract: Granzyme B inhibitor compounds, compositions that include the compounds, and methods for using the compounds. The compounds of the invention have advantageous water solubility and effectively inhibit Granzyme B.
    Type: Application
    Filed: March 27, 2017
    Publication date: March 1, 2018
    Applicant: viDA Therapeutics Inc.
    Inventor: Dale R. Cameron
  • Pyrrole compounds as Granzyme B inhibitors
    Patent number: 9849112
    Abstract: Pyrrole compounds as Granzyme B inhibitors, compositions that include the compounds, and methods for using the compounds. Method for treating cutaneous scleroderma, epidermolysis bullosa, radiation dermatitis, alopecia areata, and discoid lupus erythematosus are provided.
    Type: Grant
    Filed: September 29, 2016
    Date of Patent: December 26, 2017
    Assignee: viDA Therapeutics Inc.
    Inventor: Dale R. Cameron
  • AZAINDOLINE COMPOUNDS AS GRANZYME B INHIBITORS
    Publication number: 20170218014
    Abstract: Azaindoline compounds as granzyme B inhibitors, compositions that include the compounds, and methods for using the compounds. Methods for treating cutaneous scleroderma, epidermolysis bullosa, radiation dermatitis, alopecia areata, and discoid lupus erythematosus are provided.
    Type: Application
    Filed: July 31, 2015
    Publication date: August 3, 2017
    Applicant: viDA Therapeutics Inc.
    Inventor: Dale R. Cameron
  • CYCLIC UREA COMPOUNDS AS GRANZYME B INHIBITORS
    Publication number: 20170209608
    Abstract: An ultraviolet (UV) disinfection unit for disinfecting catheter line connections is provided. The unit can be used to disinfect solution set and transfer set catheters used for peritoneal dialysis. The unit can comprise a concavely curved bottom surface. A tubing trough of the unit can allow for ambidextrous positioning.
    Type: Application
    Filed: September 17, 2015
    Publication date: July 27, 2017
    Applicant: viDA Therapeutics Inc.
    Inventor: Dale R. Cameron
  • Indoline compounds as granzyme B inhibitors
    Patent number: 9605021
    Abstract: Granzyme B inhibitor compounds, compositions that include the compounds, and methods for using the compounds. The compounds of the invention have advantageous water solubility and effectively inhibit Granzyme B.
    Type: Grant
    Filed: September 29, 2015
    Date of Patent: March 28, 2017
    Assignee: viDA Therapeutics Inc.
    Inventor: Dale R. Cameron
  • PYRROLE COMPOUNDS AS GRANZYME B INHIBITORS
    Publication number: 20170015705
    Abstract: Pyrrole compounds as Granzyme B inhibitors, compositions that include the compounds, and methods for using the compounds. Method for treating cutaneous scleroderma, epidermolysis bullosa, radiation dermatitis, alopecia areata, and discoid lupus erythematosus are provided.
    Type: Application
    Filed: September 29, 2016
    Publication date: January 19, 2017
    Applicant: viDA Therapeutics Inc.
    Inventor: Dale R. Cameron
  • PROLINE COMPOUNDS AS GRANZYME B INHIBITORS
    Publication number: 20170015706
    Abstract: Proline compounds as Granzyme B inhibitors, compositions that include the compounds, and methods for using the compounds. Methods for treating cutaneous scleroderma, epidermolysis bullosa, radiation dermatitis, alopecia areata, and discoid lupus erythematosus are provided.
    Type: Application
    Filed: September 29, 2016
    Publication date: January 19, 2017
    Applicant: viDA Therapeutics Inc.
    Inventor: Dale R. Cameron
  • COVALENT GRANZYME B INHIBITORS
    Publication number: 20170015707
    Abstract: Covalent Granzyme B inhibitors, compositions that include the compounds, and methods for using the compounds. A method for treating cutaneous scleroderma, epidermolysis bullosa, radiation dermatitis, alopecia areata, and discoid lupus erythematosus are provided.
    Type: Application
    Filed: September 29, 2016
    Publication date: January 19, 2017
    Applicant: viDA Therapeutics Inc.
    Inventor: Dale R. Cameron
  • Proline compounds as Granzyme B inhibitors
    Patent number: 9458193
    Abstract: Proline compounds as Granzyme B inhibitors, compositions that include the compounds, and methods for using the compounds. Methods for treating cutaneous scleroderma, epidermolysis bullosa, radiation dermatitis, alopecia areata, and discoid lupus erythematosus are provided.
    Type: Grant
    Filed: July 31, 2015
    Date of Patent: October 4, 2016
    Assignee: viDA Therapeutics Inc.
    Inventor: Dale R. Cameron
  • Pyrrole compounds as granzyme B inhibitors
    Patent number: 9458138
    Abstract: Pyrrole compounds as Granzyme B inhibitors, compositions that include the compounds, and methods for using the compounds. Method for treating cutaneous scleroderma, epidermolysis bullosa, radiation dermatitis, alopecia areata, and discoid lupus erythematosus are provided.
    Type: Grant
    Filed: July 31, 2015
    Date of Patent: October 4, 2016
    Assignee: viDATherapeutics Inc.
    Inventor: Dale R. Cameron
  • Covalent granzyme B inhibitors
    Patent number: 9458192
    Abstract: Covalent Granzyme B inhibitors, compositions that include the compounds, and methods for using the compounds. A method for treating cutaneous scleroderma, epidermolysis bullosa, radiation dermatitis, alopecia areata, and discoid lupus erythematosus are provided.
    Type: Grant
    Filed: July 31, 2015
    Date of Patent: October 4, 2016
    Assignee: viDA Therapeutics Inc.
    Inventor: Dale R. Cameron
  • INDOLINE COMPOUNDS AS GRANZYME B INHIBITORS
    Publication number: 20160083422
    Abstract: Granzyme B inhibitor compounds, compositions that include the compounds, and methods for using the compounds. The compounds of the invention have advantageous water solubility and effectively inhibit Granzyme B.
    Type: Application
    Filed: September 29, 2015
    Publication date: March 24, 2016
    Applicant: VIDA THERAPEUTICS INC.
    Inventor: Dale R. Cameron